US healthcare expenditures forecast into the new millennium Eugene Sorkin Newsletter Article 11 February 2013 Pages: 3 - 4
Switching oral aciclovir to OTC status not justified in genital herpes Newsletter Article 11 February 2013 Pages: 4 - 4
Alzheimer’s model developed to evaluate treatment benefits Newsletter Article 11 February 2013 Pages: 5 - 5
Aminoglycoside monitoring cost saving in febrile neutropenia Newsletter Article 11 February 2013 Pages: 5 - 5
Risperidone in schizophrenia - additional cost justified? Newsletter Article 11 February 2013 Pages: 6 - 6
Mandatory vs voluntary screening for HIV infection in pregnancy Newsletter Article 11 February 2013 Pages: 7 - 7
Tazobactam/piperacillin in respiratory and intra-abdominal infections Newsletter Article 11 February 2013 Pages: 8 - 8
Attempts to assess the economics of quinolones in Canada Newsletter Article 11 February 2013 Pages: 8 - 9